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ABSTRACT 
Introduction: The literature on chronic care describes a gap between what patients 
need and what healthcare provides. In rheumatoid arthritis, major medical advances 
have taken place in recent years which have made it possible to successfully treat more 
patients. However, these advances have led to organizational challenges in the man-
agement of healthcare delivery. 
 
Aim: To explore the challenges in rheumatology care management by studying users’ 
perceptions of the Feed Forward System (FFS) principles (Study I), simulation model-
ing as a tool for chronic care improvement (Study II and Study IV), and a way to test 
new chronic care processes (Study III). 
 
Method: Qualitative and quantitative research methods were used to explore the chal-
lenges faced by providers and their patients at Swedish rheumatology clinics. Methods 
include interviews, a focus group discussion, questionnaires, a meta-analysis, and simu-
lation modeling. Content analysis was used to analyze qualitative data.  
 
Findings: Patients became more involved in and informed about their own care when 
they used the FFS. Providers said that it offered an overview of past treatments and 
their effects, as well as support for treatment decisions (Study I). Simulation modeling 
provided a way to test the effects of moving from time-centric to need-centric processes 
in rheumatology care (Study III). Simulation modeling was also shown to support 
healthcare improvement by visualizing the effects of planned changes, communicating 
these changes to management, and engaging providers to explore and test innovative 
solutions (Study II and IV).  
 
Discussion: Feed Forward Systems and simulation modeling represent an upgrade of 
how to manage the challenges inherent to rheumatology care. FFS encourage patient 
empowerment, self-management, and shared decision making, as well as support learn-
ing for patients and providers alike. Simulation modeling helps manage complex prob-
lems and facilitates learning for providers and managers. This is enabled through the 
shared features of FFS and simulation modeling: (1) the transformation of data into 
knowledge, (2) a mutual communication platform for multiple stakeholder involve-
ment, (3) provision of real time feedback that enables action in clinical practice, and (4) 
self-correction that generates learning opportunities.  
 
Conclusion: The introduction of FFS and simulation modeling has implications at the 
clinical level and the patient level of rheumatology care. Upgrading chronic care where 
it is delivered, at both levels, can contribute to improvements in care management – 
changing the healthcare system from within. 
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MY JOURNEY 
She was crying from the pain and she was frustrated not being able to get up from the 
chair in the waiting room. She was no more than twenty-five, much younger than the 
other patients and her anxious mother stood next to her trying to help her. 
 
This was one of my first experiences with chronic care and rheumatology as I conduct-
ed my Master’s thesis in medical informatics, that later was transformed into Study I. 
As a student I realized early on that my interest was not in coding or building ICT sys-
tems, but rather in understanding how they were used and perceived by the user. This is 
what I had the opportunity to do at the rheumatology clinic - studying patients’ and 
providers’ experiences in using a Feed Forward System.  
 
Since then, rheumatology has continued to be the context of my research. Prior to my 
doctoral studies, I worked as a project manager for the Swedish Rheumatology Quality 
register (SRQ). During two years I visited 23 rheumatology clinics and met with over 
200 healthcare professionals. This great opportunity allowed me to observe the daily 
care and challenges in rheumatology.  
 
I was introduced to simulation modeling when trying to find ways to manage one of 
these challenges: access. As I learned more about simulation modeling I realized it is 
difficult to find information and cases on this practice in Sweden. This difficulty in-
spired me to perform Study II. Study III allowed me to work with and explore a real 
problem in a virtual reality as I tried to improve access. The clinical use and the value 
of the simulation model was always important and guided Study IV in which I explored 
the model’s ability to support health care improvement.  
 
Reconnecting to informatics, both Feed Forward Systems and simulation modeling are 
methods for the collection and management of data in order to inform patients, doctors, 
and organizations on how to improve care and its delivery. The title of this thesis sug-
gests that chronic care can be improved using informatics and ICT tools, hence the up-
grade. The upgrade is not simply a technical one since it aims to empower patients and 
providers in their respective roles when interacting, generating knowledge from testing, 
evaluating the effects of improvement initiatives, and managing the complex reality 
they are part of. 
 
This was a short summary of my journey and the pieces that form this thesis. To illus-
trate the patient perspective on the challenges and developments, the past and the pre-
sent within rheumatology, a patient journey follows next. 
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THE PATIENT JOURNEY 
First, my feet hurt every time I got out of bed. I blamed it on dancing in high heels. 
Then my feet started to hurt every time I got up from a chair. I didn’t want to 
acknowledge the pain or the problem. When I could no longer use my arms, I realized 
something was very wrong...  
 
Carina was only 27 years old when she was diagnosed with rheumatoid arthritis. The 
day of her diagnosis, in May 1989, was the last time she would wear high heels. Carina 
and her husband have two daughters and her youngest was only about one year old 
when the diagnosis was made. At first the doctors did not understand what was wrong 
with Carina. It was almost a year after her symptoms first appeared that a rheumatolo-
gist made a correct diagnosis.  
 
With the first appearance of these symptoms Carina did not want to admit that some-
thing was wrong. Three years after her first meeting with the rheumatologist, she still 
did not want to admit she had the disease. The other patients in the waiting room were 
old ladies, and she was not one of them. Carina thought something else was causing her 
pain. She still refused to admit to her family that she was very ill, especially because 
she did not want her daughters to suffer.  
 
When Carina finally understood that her disease was a reality, she began gathering all 
the information she could. With no internet, she brought home all brochures she could 
find, talked to other patients with rheumatoid arthritis, and contacted the patient associ-
ation. Working with her family, planning carefully, and taking analgesics, she was able 
to cope with the disease. However, many friends did not realize how ill she was. She 
tried to work but was not able to drive to and from work because of the pain.  
 
When her rheumatologist transferred to another hospital, Carina felt frightened and 
isolated. There was no one she could call for advice or care if she felt worse. Lack of 
access to care was scary. When she later found a new doctor and a nurse who were 
readily accessible, she was greatly relieved. After ten years of illness, on sick leave 
from work and on medication that provided no relief, Carina had the opportunity to try 
new medications that had been recently approved for use. “It was magic!” as Carina 
exclaimed. She felt energetic again and could engage more fully in her daughters’ lives.    
 
Now, Carina meets with her rheumatologist every 4 to 5 months. When she arrives at 
the clinic she uses the Feed Forward System. She recognizes it is important that the 
doctor understands her disease and gives her the proper prescriptions. Since she under-
stands that there are variations in the severity of her disease, she knows she must adapt 
her behavior accordingly. Using the printed summary from the Feed Forward System, 
she can discuss her condition with her doctor. As she says, “I am the expert on me.” 
Carina wishes more patients would use this system as a support for the important meet-
ings with healthcare. She states: “The summary details what we have done, what has 
been decided, and empowers me until the next meeting.”  
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1 CHRONIC CARE CHALLENGES 
I will introduce this thesis with descriptions of chronic care complexity and its chal-
lenges. Especially, I will focus on the intersection between patients and chronic care 
and illustrate the importance of the needs of patients. I will use the case of rheumatolo-
gy to exemplify patient needs with focus on the areas of patient access to care and the 
interaction between patient and provider. By provider, I refer to the healthcare staff 
working with patients. For each of the two areas I will suggest approaches to manage 
present challenges. These approaches constitute the upgrade. The contexts are the clini-
cal level and the patient level. 
 
Chronic illnesses are increasingly common and cause great suffering (Shortell et al., 
2009, WHO, 2002). Because of the many patients who suffer from chronic illnesses, 
there is a need to consider the quality of chronic care, which is both complex and costly 
(Shortell et al., 2009, Ovretveit et al., 2008, Harrington, 2003, Bohmer, 2009). Many of 
the challenges in modern healthcare are present in chronic care (Yazdany and 
MacLean, 2008). Inadequacies in treatment as well as the asymmetry between patients’ 
needs and the design of the healthcare delivery system are some of the challenges fac-
ing chronic care (Bodenheimer et al., 2002, Wagner et al., 2001). 
 
To a great extent, healthcare involves processes for acute and episodic illnesses rather 
than care for chronic illnesses (WHO, 2002, Wagner et al., 2005). Effective chronic 
care requires customized care with follow-up visits focusing on the patients’ needs and 
illness severity (McCorkle et al., 2011). The evidence shows that education and health 
self-management can improve outcomes for chronically ill patients who have a lifelong 
relationship with health care (McCorkle et al., 2011, Bodenheimer et al., 2002). The 
increasing number of patients with chronic illnesses calls for action to assure care is 
provided at the right time for the right patient and to enable patients to manage their 
own health. If chronic care is improved, it will benefit a great number of patients 
(Wagner, 1997). 
 
1.1 THE CASE OF RHEUMATOLOGY  
Rheumatoid arthritis (RA) is a chronic condition. It is the most common inflammatory 
arthritis, affecting nearly 1% of the general population worldwide (Firestein and 
Kelley, 2009, Cecil et al., 2012). Globally, this means that about 70 million patients are 
suffering from RA. The prevalence of the condition is two to three times greater for 
women than for men. RA can occur at any age, but its onset between the ages of 45 and 
65 is most common (Firestein and Kelley, 2009, Cecil et al., 2012). RA is associated 
with increased mortality and patients often suffer from pain, stiffness, reduced muscu-
lar power, weakness, and fatigue (Firestein and Kelley, 2009).  
 
In the past decade, the setting of rheumatology has changed drastically. Since 1999, 
new treatments have become available, such as Tumor Necrosis Factor (TNF) inhibi-
tors. These RA treatments have had substantial effect on reducing the symptoms of the 
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disease. For many patients, quality of life has improved (Firestein and Kelley, 2009, 
Klareskog et al., 2009). However, these new achievements are associated with in-
creased costs, in particular pharmaceutical costs. For example, the annual national costs 
of antirheumatic pharmaceuticals in Sweden alone is about 1600 MSEK (SRQ, 2011)
1
. 
In 1999 the same figure was 60 MSEK annually. 
 
With more treatment opportunities available, more patients can be cared for. This is 
discernible in rheumatology care as well as in the complexity of treatment opportunities 
and combinations (SRQ, 2011). There are many diverse challenges in rheumatology 
care such as the search for appropriate quality of life indicators, the need to follow the-
se indicators longitudinally, the necessity of adherence to treatment guidelines, the dis-
parate quality of care (Yazdany and MacLean, 2008), the problem of uncoordinated, 
ineffective and even unnecessary treatments (Harrington, 2008), delayed referral pro-
cesses, limited access, inadequate routines for follow up visits (Newman and 
Harrington, 2007, Harrington, 2003), and staff shortages (Gartner et al., 2012).  
 
The main challenges, that have been reported in Swedish rheumatology care are exces-
sive patient waiting times and staff shortages (Eriksson et al., 2011). Traditional solu-
tions have been attempted in Sweden to minimize or eliminate such problems. These 
solutions include staffing on a national level (Eriksson et al., 2011), internationally ad-
vanced access scheduling (Newman and Harrington, 2007), immediate access clinics 
(Gartner et al., 2012), and referral management (Harrington, 2003).  
 
Despite the recent innovations in rheumatology care, Harrington suggests that chronic 
care has been unable to satisfy the demands of society and of patients (Harrington, 
2003). Since the goal of health care delivery is to satisfy such demands  (Wagner et al., 
2001), chronic care requires customized procedures aligned with each patient’s biologi-
cal variation and disease fluctuation. To accomplish this there is a need to improve pro-
cesses and systems. However, it has been acknowledged that there is a need to expand 
knowledge and to increase research initiatives in order to redesign rheumatology care 
(Harrington, 2008, Harrington, 2003). In summary, upgrading chronic care and rheu-
matology is needed to meet the various needs of the many patients. 
 
 
 
 
 
                                                 
1
 Swedish currency rate October 2011:1 SEK = 6,44 USD//9,02 Euro 
 (Swedish Riksbank). 
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2 UPGRADING CHRONIC CARE 
It is recognized that new drugs and new therapies are not the sole solutions to better 
healthcare. The organization of healthcare is considered to be of great importance as 
well (Fulop, 2001, Bohmer, 2009). As described in the previous chapter, there are sev-
eral challenges within chronic care and rheumatology care. This chapter will further 
explore two of these challenges that are the main areas of the thesis: patient - provider 
interaction and patient access to care. According to the Chronic Care Model (CCM), 
which I use to position the four studies in a wider context, the two main areas fold into 
the subjects of Delivery System Design and Productive Interactions. First, I will give a 
short background to the concept of improvement and models in chronic care that de-
scribe the foundation of the approaches I suggest to manage the challenges posed. 
 
2.1 IMPROVEMENT 
Healthcare quality improvement initiatives are the measures aimed at improving pa-
tients’ health, bettering healthcare operations, and advancing professional development 
(Batalden and Davidoff, 2007). Such improvement proposals have had different names 
and forms over the years, including TQM (Total Quality Management), CQI (Continu-
ous Quality Improvement), Lean, Six Sigma, and BPR (Business Process Reengineer-
ing) (Chassin and Loeb, 2011).  
 
Due to the complex initiatives and the numerous contextual factors, the effects of these 
initiatives on healthcare quality have been debated (Blumenthal and Kilo, 1998, Kaplan 
et al., 2010, Thor et al., 2010). However, the evidence suggests that healthcare quality 
improvement initiatives can prevent illnesses, assess treatments, and support patients 
with chronic illnesses (Ovretveit et al., 2008). Thus, it seems that improvement can 
contribute to the upgrade of chronic care, but attention must be paid to the known chal-
lenges of improvement. 
 
The ability to design and implement change is necessary in order to improve healthcare. 
While improvements require change, not all changes result in improvements. There-
fore, an improvement requires an alteration in the performance of an operation, the 
generation and awareness of positive differences in contrast to previous results, and a 
sustainable impact (Langley, 2009). A model that ties all these parts together is the 
well-known model for improvement, Plan-Do-Study-Act (PDSA) for testing and im-
plementing change (Langley, 2009, Shewhart and Deming, 1986).  
 
The PDSA model has been used in rheumatology care improvements (Harrington and 
Newman, 2007, Newman and Harrington, 2007). The concept of the PDSA cycle is to 
start with the aim, and the appropriate measurements and then to develop a plan to test 
a change (Plan), perform and implement the test in reality (Do), observe and learn from 
the consequences and effects of the change (Study) and finally to determine what modi-
fications should be made in order to inform the next cycle (Act). 
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2.1.1 Models and frameworks in chronic care improvement 
There are various evidence-based models and programs for managing chronic care 
(Ovretveit et al., 2008). Ample research on chronic care improvement stems from the 
work of Edward Wagner, creator of the Chronic Care Model (CCM). The CCM is a 
conceptual model based on evidence for improving the care of patients with chronic 
illnesses (Wagner et al., 2005, Wagner et al., 2001). The CCM is built upon the follow-
ing components: self-management support, delivery system design, decision support, 
and clinical information systems (Bodenheimer et al., 2002) (see Figure 1).  
 
Related to the CCM, Wagner (1997) identifies success factors that aim to improve 
chronic care: (1) the use of plans and evidence-based guidelines, (2) reorganization of 
practice to meet patients’ needs, (3) attention to the psychosocial needs of patients and 
appropriate behavior changes, (4) access to expertise, and (5) supportive information 
and communication technologies ICT (Wagner, 1997). The studies of this thesis will in 
particular focus on numbers 2, 4 and 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The Chronic Care Model (CCM). 
 
Due to the increasing number and growing cost of chronic illnesses, the CCM was,  
with the assistance of the World Health Organization (WHO) updated in an effort 
called the “Innovative Care for Chronic Conditions” (WHO, 2002). The new model, 
the Innovative Care for Chronic Conditions (ICCC) Framework was a redesign of the 
CCM to suit an international context and a variety of healthcare systems (Epping-
Jordan et al., 2004, Nuno et al., 2011). Evidence of the effect of the ICCC Framework 
is more limited than the evidence of the effect of the CCM (Nuno et al., 2011, Wagner 
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et al., 2001). The CCM focuses on the need to re-organize healthcare systems, whereas 
the ICCC Framework emphasizes coordination and integration (Nuno et al., 2011).  
 
Since the focus of the four studies (Studies I, II, III and IV) presented in this thesis is 
the upgrade and redesign of chronic care, I will use the CCM as a conceptual model to 
position the studies. The main areas of my research according to the CCM are within 
the areas of Health Systems and Productive Interactions. Study I mainly concerns the 
productive interactions between patient and provider. Study II presents work on differ-
ent levels in the healthcare context with a focus on Delivery System Design. Study III 
and Study IV deals with delivery system design and new perspectives on decision sup-
port with close connections to the providers’ work. 
 
Care Management Processes (CMP) includes actions developed to improve the quality 
of care for patients with chronic illnesses (Shortell et al., 2009, Casalino et al., 2003). 
Several of these actions are related to the work of this thesis. CMP comprises the use of 
disease registries to identify patients with chronic illnesses, development of patient ed-
ucation programs to help patients better manage their illnesses, use of nurse care man-
agers for the sickest patients with the most complex needs, provision of feedback to 
doctors on their performance, and reminders and decision support information for pro-
viders and patients at the time of care (Shortell et al., 2009, Wagner et al., 2001, 
Wagner et al., 1996). The use of CMP has proved effective in improving healthcare 
(Shortell et al., 2009).  
 
The next sections present an overview of the main areas of the thesis: Productive Inter-
actions exemplified by patient–provider interaction and Delivery System Design with a 
focus on health care access in rheumatology care. These two areas are the challenges 
that I have had the opportunity to research and that are important to both patients and 
health care providers. The approaches of the FFS and simulation modeling will be de-
scribed in further detail and connect to the respective challenge.    
 
2.2 PRODUCTIVE INTERACTIONS 
The following section takes on the next action step after granted access to healthcare, 
the patient–provider interaction, referred to as Productive Interactions in the CCM. This 
is also the first main area of this thesis. Patients with chronic illnesses manage their 
health every day and should not be considered only as receivers of care. Instead, they 
are also co-producers of care. This observation has implications for a new patient-
professional partnership, involving collaborative care and self-management education 
(Bodenheimer et al., 2002).  
 
2.2.1 Patient–Provider interaction 
The basis for how patients can contribute to their own care (i.e., self-management) until 
the next visit is established in the interaction between patient and provider during the 
clinical appointment. Education, communication, participation, motivation and shared 
decision-making are factors in this interaction (Daltroy, 1993, Teutsch, 2003). The out-
come of the interaction plays an important part in patient satisfaction (Teutsch, 2003). 
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Patient engagement is considered to involve: informing patients, teaching them skills, 
and building their self-confidence so that they can engage in self-management 
(McCorkle et al., 2011). It is imperative that patients are well-informed so that they are 
prepared to participate in setting care goals and in planning how to achieve them 
(Daltroy, 1993, Wagner et al., 2005).  
 
There is a considerable body of research on patient-provider interaction. However, re-
search has also found that still more investigation is required. For example, there is a 
need to learn how the patient and the provider can be equally active in their meetings 
(Pilnick and Dingwall, 2011). Patient centered care is an important area of health care 
in the 21
st
 century but the impact on patient health outcomes varies (Pilnick and 
Dingwall, 2011). Moving from patient centered care towards empowering partnering 
has been advocated in chronic illness where co-creation and cooperation are empha-
sized (McWilliam, 2009).  
 
Educational programs have been shown in the past to be efficient but few patients par-
ticipated (Daltroy, 1993). Research also describes a mismatch about patient infor-
mation: what the patient seeks is not necessarily what the provider offers. Moreover, 
patients with chronic illnesses have different information needs than patients with acute 
illnesses (Daltroy, 1993). The research also recommends various patient-provider inter-
action tasks related to their communication. For instance, it is recommended that pro-
viders give specific (rather than general) instructions and present organized and sum-
marized information in easily readable formats (Daltroy, 1993).  
 
Patient self-management is an important aspect of chronic care. A randomized con-
trolled trial performed by McCorkle et al. (2011) describes the benefits of self-
management in oncology patients. It has been found that patients who are capable of 
self-management can solve problems, make decisions, use resources efficiently, form 
partnerships with providers, and take action (McCorkle et al., 2011). In short, self-
management allows patients to become more active in their own care which can help 
shape the interactions with healthcare (Bergman et al., 2011, Wagner, 1997).  
 
Shared decision-making is a joint collaboration between patient and provider in making 
decisions on future actions, such as treatment plans, and connects to patient centered 
care and patient empowerment (Whitney et al., 2004). It is acknowledged as an im-
portant part of the patient-provider interaction that also stresses the need for sharing 
information (Elwyn et al., 2000). Past research in shared decision making has focused 
on situations where there is more than one choice available and the importance of 
achieving a mutual agreement between patient and provider (Whitney et al., 2004, 
Frosch and Kaplan, 1999). Recent research also include situations where there is only 
one choice and when agreement is not reached, stressing the importance of information 
and communication (Whitney et al., 2008).  
 
Information and Communications Technology (ICT) can facilitate the processes that 
are the basis for the interaction between patient and provider. A shared patient-provider 
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language is one such communication tool (McCorkle et al., 2011). Advances in ICT 
have also greatly benefited the area of chronic care. Many patients use the Internet for 
self-management support and for communication with healthcare, with other patients, 
and with various healthcare authorities (Dickerson et al., 2006). Moreover, dis-
ease/illness registries, with their real time decision support, have been identified as es-
sential communication tools (Wagner, 1997). In summary, ICT can improve chronic 
care management by engaging patients in the care process (Marchibroda, 2008). 
 
2.2.2 Feed Forward Systems 
If you search for the term feed forward in PubMed you will find many areas of applica-
tion such as physiology and gene regulation. If you Google the same term you will find 
many examples of application in computing and neural networks. The most suitable 
general description is “Feed forward is the modification or control of a process by its 
anticipated or predicted results or effects” (Brown and Little, 1993)2. Feed forward is 
not a new term but the application to be described here is novel. A suitable application 
of this definition in the context of rheumatology care management would be the use of 
the FFS aims to capture patient data at an early stage, in order to facilitate decision-
making in later stages.  
 
2.2.2.1 FFS in rheumatology 
FFS represents ways to arrange a process in which principles can be applied with the 
help of ICT to capture data, on which the decision making process can be based. The 
first ICT using FFS was developed at the Spine Center at the Dartmouth-Hitchcock 
Medical Center (DHMC), in 1999. The aim of that system was to create a common 
language (Weinstein et al., 2000). This common language enables patients and provid-
ers to communicate better about the patients’ current health status, their treatments, and 
their response to therapy (Nelson et al., 2003, Nelson et al., 2000, Nelson et al., 1998, 
Nelson et al., 1996). The FFS process is illustrated in Figure 2.  
 
 
Figure 2. The FFS process as applied to the rheumatology care context. 
 
                                                 
2
 Page 929. 
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In 2003, the Swedish Rheumatology Quality register (SRQ) implemented an ICT based 
on FFS with online access. Instead of collecting all patient data during the patient-
provider visit by asking questions, some patient data are collected from the patient prior 
to the visit. Data can either be collected at the clinic while waiting for the provider or 
from the patients’ home via a patient portal online (e.g. www.1177.se or 
www.vardguiden.se).  
 
Similar systems have been reported in rheumatology care contexts with the main aim of 
comparing the accuracy of patients’ reported health status via standardized paper ques-
tionnaires and computerized questionnaires (Richter et al., 2008, Greenwood et al., 
2006). Conclusions revealed that computerized questionnaires accessed from a touch 
screen computer can generate results comparable to those of the paper version.  
 
 
 
Figure 3. Patient entering data on swollen and tender joints using the touch screen in the Swedish 
rheumatology setting. 
 
The Swedish FFS process begins when patients fill out an electronic self-administered 
health survey prior to their visit (see Figure 2). This is done using a touchscreen com-
puter in the waiting area to enter data on their pain, swollen and/or tender joints, per-
formance of daily activities, health-related life quality (using EQ-5D), and ability to 
work (see Figure 3). The data is compiled in an overview with all other information 
obtained in previous visits (see Figure 4).  
 
The overview uses color codes to illustrate the value of DAS28 using red for a higher 
DAS followed by yellow, green, and white. With this data, providers can prescribe 
treatment and medication. The printed overview is shared between patient and provider 
during the visit and functions as a basis for shared decision making. The treatment that 
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is agreed upon is entered into the system and is thus accessible to both patient and pro-
vider to complete the overview. 
 
 
 
Figure 4. The printed patient summary overview showing entered data and DAS28 (Disease Activi-
ty Score for 28 joints) over time. 
 
2.3 DELIVERY SYSTEM DESIGN  
Delivery system design involves access. The following text highlights the importance 
of access for patients with RA and simulation modeling as a way to deal with access.   
 
2.3.1 Access 
In the report, Crossing the Quality Chasm (IOM, 2001), the Institute of Medicine, in 
the US, stated that timely care is an essential factor in the treatment of all patients, re-
gardless if they suffer from acute or chronic illnesses. Delayed access to care may 
cause not only patient dissatisfaction, but also worsened illness or injury or lead to un-
necessary visits with healthcare providers (Newman and Harrington, 2007, Murray, 
2000). Access is an essential factor that can be studied in many different ways (Aday 
and Andersen, 1974, Vissers and Beech, 2005, Allder et al., 2011, Martin et al., 2003, 
Randolph, 2005, Murray, 2000).  
 
Based on these different studies of access I chose to define access in the contexts of this 
thesis as the availability of healthcare services to patients based on their individual 
needs in a timely manner. According to the framework for studying access developed 
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by Aday and Andersson (1974) there are several components that contribute to the to-
tality of access. Using their framework, the component I have chosen to focus on in this 
thesis is Healthcare whose characteristics include resources (volume and distribution) 
and the organization (entry and structure) (Aday and Andersen, 1974). The organiza-
tion aspect refers to the process of gaining entry to the system (access) and structure 
can be referred to the processes after entry, i.e. the patient–provider interaction (Aday 
and Andersen, 1974). 
 
Patients with suspected RA require prompt access to specialty care due to the narrow 
window of opportunity for treatment that is available. This window is open only for 3-6 
months after the disease onset and is when treatment has the potential to generate best 
effect (Lard et al., 2001, Nell et al., 2004). 
 
2.3.2 Access in the context of rheumatology 
Hence access for this group of patients is important and treatment within the window is 
recommended in guidelines. Patients with a confirmed diagnosis of RA also require 
prompt access to care since many of them receive aggressive treatments with TNF in-
hibitors that require follow-up. Long waiting times to specialists care are one obstacle 
to access. An Estonian study concluded that the traveling distances to specialists, as 
well as the long waits for specialist appointments, caused patients to consult general 
practitioners instead of specialists (Polluste et al., 2011).  
 
The literature shows various strategies to improve access in rheumatology care. These 
include referral management (Harrington, 2003) and immediate access clinics (Gartner 
et al., 2012). It has also been suggested that rheumatology nurses may care for certain 
groups of patients who do not require an immediate appointment with a doctor. These 
nurses may give patients information and make telephone follow-up calls (Gartner et 
al., 2012, Wagner, 2000).  
 
2.3.3 Open clinic 
The concept of Open clinic or patient driven access was tested in a randomized con-
trolled trial during six years. Patients in the intervention group, with low DAS28, were 
given direct access based on their individual needs and not offered any routine follow 
up visits. The clinical and psychological status of the patients in the intervention group 
was evaluated after six years. They performed as well as the patients in the control 
group whose visits were initiated by a rheumatologist (Hewlett et al., 2005). When pa-
tients reach a lower DAS28 they can enter the Open clinic process and contact their 
rheumatologist when needed.  
 
2.3.4 Tight clinic 
Another approach is the Tight clinic or tight control that aims to intensify treatment 
management for patients suffering from RA with a high DAS28. A randomized con-
trolled trial aiming to compare tight control of the disease activity with routine outpa-
tient care showed that patients in the tight control group achieved a greater response to 
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treatments and a decrease of disease activity than those in the control group (Grigor et 
al., 2004). Recent findings support frequent appointments as suggested in the Tight 
clinic, which is now recommended for patients with RA (Bakker et al., 2011). Belong-
ing to the Tight clinic implies that the DAS28 is high. In this case, patients will meet 
with their rheumatologist with tight time intervals in order to evaluate treatment effects 
and adjust treatment plans to lower DAS28.  
 
In both Open and Tight clinics, the Disease Activity Score for 28 joints (DAS28) was 
used to evaluate patients treatment response. DAS28 is a composite measure of the 
individual patient’s number of swollen and tender joints, ESR (Erythrocyte Sedimenta-
tion Rate) or CRP (C-reactive protein) and global health (Wells et al., 2009). A low 
DAS28 reflects low disease activity or remission; a high DAS28 reflects high disease 
activity. 
 
Access is an important aspect of rheumatology. The advantages of using Open and 
Tight clinics are the improved access and the opportunity of improved patient out-
comes. Combining these concepts, simulation modeling could be a valuable tool to 
assess its impact on a clinical level. 
 
2.3.5 Simulation modeling 
When thinking about simulation, computer games, weather forecasts, or flight simula-
tors often come to mind. Essential aspects in all types of simulation involve testing, 
training, and learning to prepare for reality (Slovensky and Morin, 1997, Sterman, 
2006). In healthcare simulation, people usually refer to practical training in surgical 
skills, acute care, or virtual patients. Access, patient flow, resource allocation and staff 
scheduling are examples of areas where process simulation has been applied 
(Aharonson-Daniel et al., 1996, Elbeyli and Palaniappa, 2000, Hung et al., 2007, 
Vermeulen et al., 2009, Elkhuizen et al., 2007).  
 
Simulation modeling stems from Operations Research (OR), an area of research con-
cerned with solving operational problems (Hillier and Lieberman, 2010). OR, some-
times used synonymously for Management Science (MS) (Hillier and Lieberman, 
2010), aims to improve operations within organizations by using system models 
(Hillier and Lieberman, 2010, Pidd, 2003, Pidd, 2004b, Fulop, 2001). Different quanti-
tative approaches and mathematical tools (e.g., statistics and decision modeling) are 
used in OR. These tools can also be used to improve healthcare (Fulop, 2001).  
 
Simulation modeling allows creating and testing prototypes of changes before they are 
implemented in reality. It offers safe environments for testing and learning where time 
and space can be compressed (Slovensky and Morin, 1997, Sterman, 2006). It also can 
function as a systems analysis tool (Reid et al., 2005) making it possible to imitate or 
replicate an already existing system (Robinson, 2004, Slovensky and Morin, 1997). 
This is of particular importance when one is interested in looking at a complex system 
such as healthcare with its many components and interactions (Slovensky and Morin, 
1997, Sterman, 2006).  
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2.3.5.1 Simulation methods 
There are three multi-paradigm simulation modeling methods of relevance to this the-
sis; System Dynamics (SD), Agent Based Modeling (ABM), and Discrete Event Simu-
lation (DES). Other methods identified in Study II such as Monte Carlo and Markov 
modeling are not of relevance to this thesis discourse. The three major methods are 
compared in depth in Study II but to understand some of their similarities and differ-
ence I present a short overview here.  
 
In the 1950s the American computer engineer, Jay Forrester, founded the method, 
which is called System Dynamics (SD). This methodology is used to understand the 
structure, dynamics, and behavior of complex systems (Sterman, 2000). SD, which has 
its roots in differential equations (Gilbert and Troitzsch, 2005), emphasizes the im-
portance of feedback control and delays (Pidd, 2003). SD cases often span several or-
ganizational boundaries and take on the macro view (Taylor and Lane, 1998, Gilbert 
and Troitzsch, 2005). This method has been applied in many areas of public health and 
social policy (Homer et al., 2007, Homer et al., 2004, Homer et al., 2008, Homer and 
Hirsch, 2006).  
 
Agent Based Modeling (ABM), which was introduced in the 1990s, is a fast growing 
simulation method. ABM models agents and their interaction with each other and with 
their context (Gilbert and Troitzsch, 2005). ABM involves autonomous but rule-based 
agents, for example, people, hospitals, cars, and companies and is a popular method in 
studying complex social phenomena (Deguchi et al., 2006, Arai et al., 2005). ABM has 
been used, among other things, to examine human behavior and to study the spread of 
human immunodeficiency viruses, influenza, and the health and safety of populations 
(Anderson et al., 2007, Lee et al., 2008).  
 
A frequently used simulation method for healthcare processes is the process-centric 
method called Discrete Event Simulation (DES), stemming from the 1960s. DES repre-
sents the components of a system and their interactions (Banks, 1998) that are often 
used for local and clinic decisions (Taylor and Lane, 1998). These components or ob-
jects are called entities and represent important features of a given system, i.e. patients, 
doctors or nurses. Groups of entities are named classes. The entities will change state 
during the simulation run, for example from referred patient to hospitalized to dis-
charged (Pidd, 2003). DES looks at specific points in a given process (e.g., patient–
provider meetings) and at the chronological sequence of events (Chase and Jacobs, 
2006, Gilbert and Troitzsch, 2005, Robinson, 2004). The state of the system observed 
and simulated is updated as each event takes place. Events changes the state of the sys-
tem representing how the real system changes over time (Law and Kelton, 2000).  
 
DES, which has been used at various levels of healthcare, focuses on a variety of prob-
lems such as patient flows, resource allocation, and staffing scheduling (Günal and 
Pidd, 2010) is a suitable tool to evaluating and improving system performance 
(Mustafee et al., 2010). Questions suitable for testing in a simulation model begin with 
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what if, which allows for a wide variety of experimentation in healthcare. Examples of 
such questions are: What if we hire another nurse? What if we have to cut the budget by 
10 %? What if we had another three beds or two more examination rooms? (Pidd, 
2004a, Robinson, 2004). 
 
2.4 SUMMARY 
In this section I have attempted to describe the challenges of chronic care, specifically 
in the context of rheumatology care. Two challenges have emerged, explicitly patient 
access and patient–provider interaction. A number of improvement methods and con-
ceptual models exist all of which have their strengths and limitations. To meet the chal-
lenges of rheumatology, the approaches of FFS and simulation modeling are proposed. 
These approaches can form an upgrade and potentially contribute to the improvement 
of rheumatology at the clinical level with implications for both patients and healthcare 
providers. 
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3 AIM AND OBJECTIVES 
 
3.1 GENERAL AIM 
The general aim of this thesis is to explore challenges in rheumatology care manage-
ment. This involves exploring users’ perception of two ICT systems based on Feed 
Forward System principles, exploring simulation modeling as a tool in chronic care 
improvement and using simulation modeling to test new chronic care processes. 
 
3.1.1 Specific objectives 
The specific aims and objectives of the four studies included in this thesis are to: 
 
- Identify and describe the essential properties of FFS and explore patients’ and 
providers’ perceptions in two different healthcare contexts, the U.S and Sweden 
(Study I) 
 
- Investigate the experience and potential value of simulation modeling when used 
in healthcare decision making and assess the quality of identified evidence 
(Study II) 
 
- Compare two approaches to health care delivery in a rheumatology outpatient 
clinic in a simulation model (Study III) 
 
- Describe the experience of using simulation modeling as a tool in healthcare im-
provement, and explore one method to investigate the value of simulation mod-
eling (Study IV) 
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4 OVERVIEW OF THE THESIS 
The four studies in this thesis can be seen as contributing to exploring rheumatology 
care at two different contextual levels, that of the patient and the clinic (see Figure 5). 
The thesis begins with identifying how FFS can be used to support patient provider 
interactions (Study I). To effect changes at the clinical level (e.g., managing access to 
care and waiting times), the attention in Study II turns to simulation modeling as a 
method to test proposed changes before they are implemented in reality. This study 
poses the following questions: How can simulation facilitate decision making in health 
care? What has been learned from the implementation experiences?   
 
Figure 5. Overview of the thesis. 
 
The feasibility of simulation models is explored and compared in the wider context of 
healthcare (Study II) and in the specific context of rheumatology care (Study III). 
Keeping in mind the issues of care access and waiting times, in Study III simulation 
modeling is applied in the context of rheumatology care. The goals of this study are to 
understand how to deal with the ever-increasing health care demands and with the need 
for health care to be designed to match the varying biological processes and patient 
needs and to ensure access. 
 
The knowledge gained in Study II and Study III is then applied in order to move from a 
simulation model to real world change. In Study IV, the simulation model developed in 
Study III was applied but now in a new clinical context. The goal is to describe the ex-
perience of simulation modeling in healthcare improvement and its potential value. 
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5 METHODS  
Multiple methods were used in order to explore challenges in rheumatology care man-
agement and test ways to deal with them. This section describes the study context and 
design. 
 
5.1.1 Study context 
The study context of this thesis is rheumatology care in Sweden. Three rheumatology 
clinics were selected: Karolinska University Hospital, Solna, in Stockholm (Study I and 
Study III); Sahlgrenska University Hospital in Göteborg (Study I); and Sunderbyn 
Hospital in Luleå (Study IV). Study I also includes data from the Spine Center at the 
Dartmouth-Hitchcock Medical Center (DHMC) in the United States.  
 
Sweden has 20 counties and 290 municipalities. The counties are responsible for the 
organization of health services that are financed by taxes and are controlled by national 
government policies and guidelines (Swedish Association of Local Authorities and 
Regions, 2012, Anell, 2005). Public producers mainly provide these services, although 
the number of private producers, also publicly financed, is increasing (Anell, 2005).  
 
5.1.2 Swedish Rheumatology Quality registry (SRQ) 
The Swedish Rheumatology Quality registry (SRQ) is a specialty oriented, multicenter, 
practice-based, longitudinal database in place since 1995. It is used for patients with 
rheumatic diseases who meet certain formal diagnostic criteria including a core set of 
rheumatoid arthritis-related outcome measures (Arnett et al., 1988, Felson et al., 1993). 
All 64 rheumatology units in Sweden use the SRQ to follow the progress of patients 
(n=42 700) over time.  
 
The web version of SRQ, which was launched in 2003, uses real time, standardized 
data provided by patients and doctors. DAS28 is used as a measure of individual pa-
tients’ disease activities and treatment responses. The purpose of the SRQ is to improve 
the care of patients and to support self-management. It is also used to track quality im-
provement and to support research (SRQ, 2011). 
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5.2 STUDY DESIGN 
Table 1 presents an overview of the four studies including study design, data collection, 
study focus, and data analysis.  
 
Study Study Design Data Collection Study Focus Data Analysis 
I Qualitative and 
quantitative 
Interviews and questionnaires FFS* Qualitative content 
analysis and Fish-
er’s exact 2-tailed 
test 
II Meta-analysis Database search Implementation 
experience and 
value of simulation 
modeling 
MQR and AQR** 
III Discrete Event 
Simulation 
 
Review of medical record, 
quality register and clinical 
process data 
Open Tight clinic Descriptive statis-
tics 
IV Qualitative Focus group discussion and 
interviews 
Simulation modeling 
workshop 
Qualitative content 
analysis 
 
Table 1. An overview of methods used in each study. * FFS = Feed Forward Systems ** MQR = 
Minimum Quality Requirements, AQR = Added Quality Requirements 
 
5.2.1 Study I  
Study I uses both qualitative and quantitative methods. The research team developed a 
questionnaire and interview guides that were then used in a small pilot (n=10) study in 
Sweden. Data from that pilot were not used in the data analysis. After minor adjust-
ments, the questionnaire and interviews were used at Karolinska University Hospital 
and Sahlgrenska University Hospital. The questionnaire and interview guides were then 
translated for use at the DHMC Spine Center in the second part of this study. DHMC 
researchers made minor additional adjustments to the questionnaire and interview 
guides. 
 
Patients were asked to participate in the study when they entered the clinics. All partic-
ipation was voluntary. Patients were informed that their data would be treated with con-
fidentiality. Informed consent was obtained verbally. Patients who agreed to participate 
in the study completed a questionnaire after using the Feed Forward System (FFS). 
After meeting with the healthcare provider, the patients participated in brief interviews 
on how the FFS affected their visit. In Sweden, there was some difficulty finding an 
opportunity to meet with the patients. The healthcare providers caring for the patients 
who had participated were also asked to participate in the study. All healthcare provid-
ers agreed to be interviewed.  
 
The interview audio recordings and the field notes from both settings were transcribed. 
Data were then processed using content analysis; as the data were condensed, coded, 
and categorized, themes were identified (Krippendorff, 2004, Graneheim and 
Lundman, 2004). Fisher’s exact 2-tailed test was used to compare questionnaire re-
sponse patterns among patients in both settings. The value of P of less than .05 was 
used as the threshold for statistical significance. 
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In the search for the essential properties of the FFS, the following indicators were used 
in the questionnaire and the interviews: acceptance (perceived ease of use), use (actual 
use), and utility (perceived usefulness). Properties were classified as essential if they 
enabled reinforcing loops favorable to patients, providers, or to both, in clinical encoun-
ters.  
 
5.2.2 Study II 
Study II was a meta-analysis that included a literature search. The following search 
terms were used: modeling, health care, decision and simulation (with the search op-
erator AND for all the four search terms). Six electronic databases were searched 
(PubMed/MEDLINE, Web of Science, Cumulative Index to Nursing and Allied Health 
Literature, SveMed+, PsycINFO, and Business Source Premier).  
 
Selection criteria were established prior to conducting the literature search. Articles 
should: (1) have a focus on simulation modeling in healthcare associated with a case, 
(2) describe the use of simulation as a decision-support tool, (3) be written in English, 
and (4) be electronically or locally accessible. A total of 148 articles were identified in 
the search (including five articles from experts in the field). Forty-seven articles were 
excluded as they did not meet the selection criteria (see Figure 6).  
 
Figure 6. Flowchart of the meta-analysis process. 
MQR: Minimum Quality Requirements, AQR: Added Quality Requirements.  
 
The remaining 101 articles were read in full. Of these, 42 articles were excluded as they 
were not relevant to the study aims. An independent researcher performed an inter-
reliability test by reading a sample of the retrieved articles and applying the same selec-
tion criteria. The researcher’s result was consistent with the research team selections 
(94%). The retrieved material was further analyzed using the Minimum Quality Re-
quirements (MQR) and the Added Quality Requirements (AQR). 
 
5.2.3 Study III 
In Study III, a simulation model was built using Discrete Event Simulation (DES) that 
depicted a rheumatology outpatient department. DES was chosen as a method in order 
to perform a comparison of two systems (Standard and Open-Tight) involving different 
processes. Rheumatology specialists, a modeler, and the researchers performed the iter-
ative building of the simulation model. Processes were observed and data obtained dur-
ing two months at a rheumatology clinic that was selected as the model clinic. Data 
from the clinic and the SRQ were used to validate and verify the model. Data on the 
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number of patients on various waiting lists, the number of discharged patients, and the 
number of patient visits (by specialist and by day) were retrieved from the EHR (Elec-
tronic Health Record).  
 
Two specialists helped to map the processes based on brief observations at the clinic. 
Process maps of the clinic’s standard clinic processes (see Figure 7) and the interven-
tion processes of the Open-Tight system (see Figure 8) were implemented into the sim-
ulation model using software AnyLogic™ version 6.5 (XJTechnologies, 2012). The 
SRQ annual reports provided data on the variations in the DAS28. The rules and logic 
according to the two different systems were retrieved from the articles describing Open 
and Tight clinics and were complemented by data from the model clinic where needed. 
Further rules and logic were then implemented into the model. 
 
The DAS28 value controls if the patient should go to the Open or the Tight clinic. If 
DAS28 is ≥ 3.2 the patient belongs to the Tight clinic and if DAS28 is < 3.2 the patient 
belongs to the Open clinic. Patients who cannot belong to either Open or Tight due to 
systemic diagnosis, for example, enter a separate process called Open-Tight Special 
(OTS). When patients belong to the Open clinic they are scheduled for regular follow 
up appointments with a nurse based on treatment.  
 
Appointments in the Tight clinic are scheduled with tight time intervals. When patients 
in the Tight clinic reach low disease activity they are invited to join the Open clinic and 
vice versa. Acute appointments are incorporated into the model and can occur if a pa-
tient experiences sudden decreased health status. Acute appointments are scheduled as 
soon as possible and occur randomly and equally frequent in both the Standard and 
Open-Tight system. In the Open-Tight system both doctors and nurses perform visits, 
whereas only doctors perform visits in the Standard clinic. The three initial visits are 
always performed by a doctor in order to follow up treatment responses.  
 
To implement the actual waiting times and number of patients on the waiting lists, the 
simulation model uses a warm up period. To compare the Standard and the Open-Tight 
system, the same patients enter both systems to follow their process of care. Given that 
the same patients, irrespective of clinical process, have the same disease diagnosis and 
prognosis, the comparison is strict. 
 
Our initial simulation setting tested different staffing variations to see their effects, es-
pecially the effects on the areas of our main interest. A staffing setup of 8 doctors in the 
Standard clinic (based on the staffing at the studied clinic) and 5 doctors and 3 nurses in 
the Open-Tight system was chosen. The cost for each resource was estimated and set 
per working hour (see parameter table 11.7 in Appendix). The model was simulated for 
ten years with a focus on a time period of four years in which the average resource uti-
lization is greater than 80 %. Data obtained from the simulations were analyzed using 
descriptive statistics.  
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Figure 7. Process map representing the Standard processes at a rheumatology clinic.  
 
 
 
 
 
Figure 8. Process map representing the processes of the Open-Tight system. 
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5.2.4 Study IV 
In Study IV, a focus group discussion as well as individual interviews were used to 
describe how providers experience the use of simulation modeling for decision support 
in healthcare improvement. The model developed from Study III was loaded with data 
from the clinic at Sunderbyn Hospital and a process for telephone consultations was 
added.  
 
Purposeful sampling was used to select providers familiar with process improvement to 
participate in a workshop about simulation and how simulation can be used to improve 
rheumatology care at their clinic (Patton, 2002). Seven participants (four doctors and 
three nurses) were considered a representative sample. The ages and clinical experienc-
es of the participants varied.  
 
The focus group discussion was preceded by a simulation workshop in the clinical set-
ting. During the workshop, the participants received a short introduction to simulation 
modeling and a demonstration of the model. The participants were given time to dis-
cuss their ideas or questions, which were then simulated in the model. 
 
Ten weeks after the workshop, interviews were conducted with two of the providers at 
the clinic, one nurse and one doctor. Interviews were conducted by telephone and also 
audio recorded. The interview questions were developed prior to the simulation work-
shop and some questions were added afterwards. 
 
5.3 DATA COLLECTION 
The data collection methods are described next as a complement to the methods de-
scribed above. 
 
5.3.1 Interviews  
Interviews are a method widely used in social sciences research. They involve a struc-
tured dialogue with a purpose (Kvale, 1996, Robson, 2002). Interviews were conducted 
in both Study I and Study IV. In Study I, the respondents were patients and providers. 
In Study IV, the respondents were providers. The interviews, which were conducted at 
the clinic (in Study I) and by telephone (in Study IV), lasted between 15 minutes and 
one hour.  
 
In Study I only the interviews conducted in English were audio recorded.  Handwritten 
notes were taken on the interviews conducted in Swedish. In Study IV all interviews 
were audio recorded. Semi-structured interview guides were used in all interviews. In 
Study I, the provider interviews were somewhat shorter in the US setting due to system 
differences. For example, the question on potential users was removed since all patients 
already used the system. All interviews were transcribed verbatim and subjected to a 
qualitative content analysis. 
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5.3.2 Questionnaires 
Questionnaires are often quantitatively designed and allows the researcher to collect 
data in a standardized form (Robson, 2002). The research team prepared the question-
naire that was first used in Study I in the Swedish setting. The questionnaire was then 
adapted for use in the US setting to suit the context and how the FFS was used within 
the clinic. Since the routines at the US clinic differed from the Swedish one regarding if 
patients had the opportunity to review their printed overview, this question was moved 
to the patient interview thus making the interviews different between the settings.  
 
The questionnaires, which were designed to complement the interviews, were given to 
the participating patients after they had completed the FFS input in order to obtain their 
opinions and accounts of their experiences. The patient questionnaire consisted of both 
closed and open-ended questions. Open-ended questions are useful because patients 
may give unexpected answers (Fowler, 2009). Response categories included 5-point 
Likert ratings, yes/no answers, and free text as appropriate for the items. Patients could 
write general comments at the end of each question and also at the end of the question-
naire. 
 
5.3.3 Focus group discussion 
Focus groups discussions, also known as group interviews, are used to investigate expe-
riences, attitudes, and emerging ideas in a group (Krueger and Casey, 2000, Pope et al., 
2002). The use of focus group discussions began in the 1920s as an area of market re-
search (Robson, 2002). As with individual interviews, a focus group discussion should 
have a purpose and a structure (Krueger and Casey, 2000, Robson, 2002).  
 
In Study IV, a focus group was assembled at the clinic. This was an environment in 
which the respondents were comfortable. During the hour of the focus group discus-
sion, two researchers, who were the moderators, audio recorded the discussion and took 
notes. It is necessary to have moderators since the strength of the focus group research 
method can also be its weakness if not well managed. The moderator has a multifaceted 
role which is to facilitate the discussion, manage the group dynamics, and create a 
sense of security and openness in the participants (Krueger and Casey, 2000, Morgan, 
1997, Fern, 2001, Robson, 2002).  
 
The focus group discussion in Study IV consisted of a homogenous group. The group 
members shared a common professional background and had similar work experiences. 
Simulation modeling was new to all of them. While facilitating communication, homo-
geneity in groups may also lead to groupthink (Robson, 2002). The moderators tried to 
ensure that all participants had the chance to speak by initially asking all of them to 
answer the same question. 
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5.4 DATA ANALYSIS 
The following sections describe the main data analysis methods used. 
 
5.4.1 Content Analysis 
Qualitative content analysis was used to analyze data in both Study I and Study IV. 
Content analysis is a commonly used method of analysis in the social sciences (Dixon-
Woods et al., 2005, Krippendorff, 2004). While there are different definitions of con-
tent analysis, Krippendorff’s definition is used here: “A research technique for making 
replicable and valid inferences from texts to the contexts of their use” 
(Krippendorff, 2004)
3
.  
 
Data analysis was inductive in both Study I and Study IV as patterns and codes were 
searched for (Patton, 2002). Of the three distinct approaches to content analysis defined 
by Hsieh and Shannon (2005), the conventional approach was used. This approach is 
suitable for analysis of phenomena in which few theories have been proposed or little 
research exists (Hsieh and Shannon, 2005). The preparation, data collection, and data 
analysis followed three general steps; (1) the preparation phase, (2) the organizing 
phase, and (3) the reporting phase (Elo and Kyngäs, 2008). The focus group discussion 
and the interviews were transcribed verbatim. 
 
Two researchers read the transcribed focus group discussion and individual interviews 
repeatedly in order to immerse themselves in the data. The analysis focused on manifest 
content. During data abstraction condensed meaning units were created and labeled 
with codes (Graneheim and Lundman, 2004). Finally, categories were created, fol-
lowed by sub-categories (Graneheim and Lundman, 2004). These categories and sub-
categories were content groups that shared a certain commonality (Krippendorff, 2004). 
In Study I, the amount of data was richer allowing themes to be created. In Study IV, 
the analysis concluded with categories. 
 
5.4.2 Meta-analysis 
Meta-analysis (also called meta-study or meta-synthesis) is a research method used to 
synthesize data from previous primary research (Dixon-Woods et al., 2005, Robson, 
2002). All such syntheses involve interpretation (Dixon-Woods et al., 2005), and most 
meta-analysis involves pooling quantitative data in order to perform statistical analysis 
on larger cohorts (Greenhalgh, 2006). Meta-analysis can also be of a qualitative nature 
and can be used in combination with literature reviews (Robson, 2002). Paterson 
(2001) uses the term meta-study to refer to this qualitative version of meta-analysis. 
 
Webster and Watson (2002) define a literature review as the creation of a knowledge 
foundation for the purpose of advancing the current state of knowledge, developing 
theory as well as identifying knowledge gaps. Greenhalgh (2006) defines a systematic 
review as an overview of primary research including defined objectives and a transpar-
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ent description of the method and the material. The steps in a systematic literature re-
view and a meta-study or meta-analysis share similarities including the retrieval and 
analysis of literature plus the contribution of novel knowledge (see Figure 6). A meta-
study has a clearer focus on analyzing, developing, and testing theory in qualitative 
research, whereas literature review aims to advance the knowledge within a certain 
research field (Levy and Ellis, 2006, Paterson, 2001). This difference is illustrated in 
Study II through the combination of the PDSA improvement model with the simulation 
model as described in Figure 9. 
 
The Minimum Quality Requirements (MQR) were applied to evaluate the quality and 
rigor of the evidence in the 59 articles. As stated by Fone et al. (2003), MQR are the 
minimum requirements needed in publications of simulation modeling research. To 
further research the question on implementation experiences and the potential value of 
simulation modeling, the MQR were complemented with the Added Quality Require-
ments (AQR) (see Table 2).   
 
Minimum Quality Requirements  (MQR) Added Quality Requirements (AQR) 
1. Aim  
2. Objective  
3. Model specification 3. 1 Modeling method specification 
(DES/SD/ABM/Monte Carlo/ Mar-
kov/Combination/Other) 
4. Parameter data 4.1 Amount of variable data 
5. Assumptions  
6. Validation 6.1 Verification 
6.2 Sensitivity analysis 
6.3 Empirical data 
7. Results  
8. Area: 
• Hospital scheduling and organization 
• Infectious and communicable diseases 
• Cost of illness and economic evaluation 
• Screening 
• Miscellaneous 
8.1 Abstraction level 
 9. Generalizability/transferability 
 10. Experience of decision support and imple-
mentation 
 
Table 2. Minimum Quality Requirements (MQR) and Added Quality Requirements (AQR) used to 
analyze retrieved articles. 
 
The MQR and the AQR were checked against the retrieved material. The purpose of 
this step was to determine if the different quality requirements were mentioned, but not 
how often or to what degree they were met.  
 
5.5 ETHICAL CONSIDERATIONS 
According to the Swedish law (SFS, 2003:460), approval from the relevant ethics 
committee is required to conduct research that implies physical or physiological influ-
ence on the participants. All studies were performed and approved by The Regional 
Ethical Review Board at Karolinska Institutet, Sweden. Protocol: 2009/895-31/5. 
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For the interviews, questionnaires and the focus group discussion in Study I and Study 
IV, all participants gave their informed consent. They were also informed about the 
voluntary nature of their participation and their right to withdraw at any time. Data are 
presented so that individual participants remain anonymous, and quotations used in 
reports do not include information that could identify the participants. Recorded inter-
views and paper questionnaires are copied and safely stored at multiple locations. Data 
needed to validate simulation models were extracted from SRQ, an EHR and hospital 
administration systems. Data were analyzed on a group level. Data from the SRQ are 
found in public annual reports, and therefore no approval was needed for their use. 
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6 FINDINGS 
The findings presented here are shown per study. 
 
6.1 STUDY I  
Feed forward systems for patient participation and provider support: adoption results 
from the original US context to Sweden and beyond 
 
The aim of Study I was to identify and describe the essential properties of the FFS and 
to explore patients’ and providers’ perceptions of the FFS in two different healthcare 
contexts – the United States, where the system was developed, and Sweden, where the 
system was subsequently adopted for use in clinical settings. Eighty-eight patients par-
ticipated in this study (US clinic n=44, Swedish clinics n=44). In addition, 13 providers 
from the US clinic and 6 providers from the Swedish clinics participated. Women com-
prised 55% of the patients at the US clinic and 70% of the patients at the Swedish clin-
ics.  
 
All participating providers at the Swedish clinics were doctors. In the US clinic, 9 of 
the providers were doctors, 2 were physiotherapists, and 2 were nurse practitioners. 
Most of the patients rated the FFS as excellent to good (United States: 84%, Sweden: 
96%, P < .001). Many patients valued the opportunity to enter data in the system prior 
to their clinical visit (United States: 41%, Sweden: 61%) (see Table 3). Patients appre-
ciated that the FFS was quick, easy, and efficient. The overview helped the patients 
track their progress and identify important topics to discuss with the providers.  
 
Questions from patient questionnaire Patients at  
US clinic in % 
(N = 44) 
Patients at 
Swedish clin-
ics in % 
(N = 44) 
P value 
Familiarity with use of computers:  
Very familiar 
Familiar 
Not familiar 
 
34 
27 
39 
 
27 
59 
14 
<0.01 
 
Willingness to enter data prior to appoint-
ment: 
Yes 
No 
Have no computer 
 
 
41 
45 
14 
 
 
61 
23 
16 
<0.1 
 
Overall impression of the system:  
Excellent 
Very good 
Good 
Fair 
Poor 
 
14 
45 
25 
9 
7 
 
30 
66 
0 
2 
0 
<0.001 
 
Table 3. Patients’ perceptions of the use of the FFS (by country setting). 
 
The patients commented about areas where they thought the FFS could be improved. 
They said that some questions were repetitive, there were ergonomic problems with the 
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workstation where the FFS was set up, extra time was needed to complete the FFS, and 
there were not given sufficient information before using the FFS.  
 
The providers reported that most patients rated the FFS as positive. They reported that 
the system facilitated provider decision making and follow-up, that it promoted better 
communication, and that it acted as a quality control instrument.  
 
 
The system makes it possible for  
the provider and me to talk about  
the important issues 
    Patient 
 
However, the providers also noted several drawbacks with the FFS. They reported that 
extra time was required to use the FFS, and data sometimes had to be entered twice 
since the FFS and the EHR were not connected with each other. Nevertheless, half of 
the providers stated that the FFS saved time, useful for managing data and for support-
ing their decisions. 
 
The essential properties of the FFS that the providers identified included the involve-
ment of patients in structured data collection before the clinical visit and the generation 
of an overview of data that enabled decision support for doctor. These properties ena-
bled patient involvement through engagement, education, and communication with the 
providers.  
 
 
Hidden information that the patient  
has may unexpectedly surface  
    Provider 
 
In summary, Study I provided feedback to system developers to use in making im-
provements to the ICT. While implementing some system improvements, I turned my 
attention to another challenge in rheumatology care management – patients’ access to 
care. The research team had been introduced to simulation modeling as a way to test 
improvements before their implementation; this is the tool I chose to use. Before creat-
ing models, I searched the literature on the effects of simulation modeling in healthcare. 
This literature search later became the meta-analysis performed in Study II. 
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6.2 STUDY II 
Managing health care decisions and improvement through simulation modeling 
 
The first aim of Study II was to investigate the experience and value of simulation 
modeling when used in healthcare decision-making. The second aim was to evaluate 
the quality of the evidence found in the research. Many models have been developed 
for numerous challenges, but there is little understanding of what happens after a model 
has been developed and provided to the stakeholder. This meta-analysis focused on 
simulation modeling when used as a tool for decision support in health care. Fifty-nine 
articles were included in this analysis, all of which were published between 1988 and 
mid-2009. Most of the articles were journal articles. They originated from 12 different 
countries, mainly the United States, Canada, the United Kingdom, and the Netherlands.  
 
In order to meet the research questions, we created, specified and used the Added Qual-
ity Requirements (AQR) to analyze the articles. Most published articles on simulation 
modeling fulfill many of these quality requirements. Sixty-two percent of the 59 arti-
cles scored 10 or more (on the 13 AQR). When information was lacking in the articles, 
it most frequently related to validity, verification, sensitivity analysis, generalizability 
or transferability, decision support, and the implementation experience. The most 
common topic in the articles dealing with simulation modeling in healthcare was hospi-
tal scheduling and organization. The second most common topic was the description of 
models for infection and communicable diseases. Discrete Event Simulation (DES) was 
found to be the most used simulation method identified on the micro and meso levels. 
On the macro level, SD (System Dynamics) was the method most frequently used. 
 
Only 14 studies (24%) offered descriptions on implementation and decision-support 
experiences. The articles that did report these findings state that simulation modeling 
can enable informed decisions, develop system knowledge, determine critical factors 
for the development of an organization, supply scenario analysis and options to choose 
from, help understand complex problems, and facilitate communication and the for-
mation of plans and directions for future work. Through instant feedback on innova-
tions and changes, analysis of different plausible scenarios, collaboration and commu-
nication around a shared view of a system and understanding how complexity works, 
simulation modeling aids decision making in health care.  
 
The meta-analysis of the findings led to the conceptualization of a model for simulation 
and improvement which was arrived at through the merger of the model for simulation 
with the model for improvement (the Plan-Do-Study-Act cycle). The PSDSA (Plan-
Simulate-Do-Study-Act) model is an attempt to enable further applications of simula-
tion modeling and increase its full use in healthcare (see Figure 9).  
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Figure 9. The PSDSA (Plan-Simulate-Do-Study-Act) model: a fusion of the conceptual model for 
improvement (the PDSA cycle) and the model for simulation. 
 
Understanding how simulation and improvement can be combined led naturally to 
questions about how simulation can be used to test hypothesis on how to improve ac-
cess to care.   
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6.3 STUDY III  
Comparing outpatient department systems: Moving from time-centric to need-centric 
care processes 
 
The aim of Study III was to compare two approaches to healthcare delivery in a rheu-
matology outpatient clinic using a simulation model. Simulation studies performed in 
the context of rheumatology are scarce, but the concept of outpatient department has 
been studied via simulation modeling quite frequently (Elkhuizen et al., 2007, Rohleder 
et al., 2007, Huarng and Lee, 1996, Chand et al., 2009). 
 
DES and the simulation software AnyLogic™ (XJTechnologies, 2012)  were used to 
construct a simulation model that depicted a rheumatology outpatient department. The 
model is a comparison of time-centric care (Standard system) with need-centric care 
(Open-Tight system). 
 
When the simulation model is operating, there are certain model outputs in focus: 
1. Number of patients in the clinical processes at any point in time 
2. Discharged patients from the Standard system and from the Open-Tight system 
3. Completed initial and follow-up visits for the Standard system and for the 
Open-Tight system 
4. Resource utilization of doctors, nurses, and rooms in the Standard system and in 
the Open-Tight system  
5. Waiting times for planned initial and follow-up visits in the Standard system 
and in the Open-Tight system  
6. Number of patients waiting for planned initial and follow-up visits in the Stand-
ard system and in the Open-Tight system  
7. Costs of the Standard system and of the Open-Tight system 
 
In accordance with the aim of this research, the factors of primary interest were the 
resource utilization, costs, and waiting times. The data from two of the simulated years 
and resources were sent to 8 doctors (doctors) in the Standard system and to 5 doctors 
(doctors) and 3 nurses (registered nurses) in the Open-Tight system.  
 
The results from the simulation model showed that there is higher utilization of re-
sources by the doctors in the Open-Tight system because of the fewer number of doc-
tors. The general high resource utilization is due to that doctors and nurses are allowed 
to begin new visits close to the clinics’ closing times. The length of waiting times for 
initial visits is similar in the two systems, but the length of the waiting time for follow-
up visits in the Open-Tight system is longer (see Table 4).  
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 Standard Open-Tight 
Resource utilization (mean) 97.1% 109% (MD) 
90.8% (RN) 
Waiting time in days (mean) 
 
IV = 0.07 
FV= 8.0 
IV = 0.5 
FV MD = 12.8  
FV RN = 5.2 
Costs in 1000 SEK (total) 16 821 13 883 
 
Table 4. Summarized results from Study III. IV = Initial Visit; FV = Follow-up visit; MD = Medi-
cal Doctor (doctor); RN = Registered Nurse. 
 
The simulation includes holiday schedules that reduce the resources during summer and 
Christmas (July 1st to August 15th and December 24th to January 7
th
) to two doctors in 
the Standard clinic and one doctor and one nurse in the Open-Tight system. The model 
showed that waiting times increased and resource utilization decreased during the 
summer and Christmas holidays.  
 
This work has resulted in a working model feasible to use when improving clinical pro-
cesses in rheumatology care. Developments of the model and results are presented in 
the discussion (in chapter 7). 
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6.4 STUDY IV  
From in-silico to in-reality – The value of simulation for healthcare improvement 
 
The first aim of Study IV was to describe the experience of using simulation modeling 
for healthcare improvement. The focus of the study was how, for whom, and when sim-
ulation modeling can support healthcare improvement. A second aim was to explore the 
use of focus group discussion as a method for evaluating simulation modeling.  
 
Two elements were critical in this research: the experience with a simulation model in a 
clinical setting, and the use of a simulation model by healthcare providers. The im-
portance of collaborative modeling and user interaction in all steps of simulation mod-
eling was strongly emphasized. Such a model should reflect the reality, the needs, and 
the visions of the organization it is designed for. As far as the workshop design, a 
common complaint by the providers was that there was insufficient time allotted to 
fully understand the model, to become familiar with it, and to begin testing ideas. How-
ever, the testing of ideas caused some participants to think more about their work rou-
tines. As a result, some new ideas were created and some old ideas were rejected. 
 
Using content analysis of the focus group discussion data, the following categories 
were identified: (1) model user, (2) model assessment, (3) model design, (4) model use, 
(5) benefit and value, (6) improvement work, (7) workshop design and (8) workshop 
outcome.  
 
Categories are presented in the domains of how, for whom and when simulation model-
ing can be used. How relates to topics that simulation modeling can facilitate with and 
for whom concerns potential users of the simulation model. When refers to situations 
where simulation modeling could be beneficial. Concerning the how domain, simula-
tion modeling was seen as a decision support tool because of its visualization of prob-
lems and potential solutions. Furthermore, simulation modeling can test ideas and 
methods of working as well as communicate planned improvements and their effects. It 
was observed that simulation modeling could benefit healthcare improvement by de-
picting problems and solutions, by generating new ideas, by inspiring colleagues, and 
by informing management of improvements and processes. 
 
By understanding that anything may  
be suggested, we can test many different  
things and start thinking outside the box.  
It is so easy to get stuck in patterns.  
Nurse 
 
In exploring the for whom domain, the focus group discussants pointed out that simula-
tion modeling can be used both at the clinical level and at the management level. How-
ever, the user needs to have an interest in and familiarity with simulation modeling. 
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Specific potential users, such as schedulers, nurse managers and heads of department, 
were mentioned.  
 
On the topic of the when domain, the focus group discussants stated that simulation 
modeling was useful in assisting in the development and testing of their ideas in the 
clinics and in showing their work and results to managers. They also commented that 
simulation modeling could present the financial aspects of changes and their budget 
implications.  
 
Simulation is a tool for information and education.  
Doctor 
 
The data analysis of the follow-up interviews revealed the following new categories: 
the (9) holistic view, (10) learning, and (11) organization. Simulation modeling can 
facilitate learning, both for the individual and the organization, when showing the ef-
fects of improvements connected to the holistic view. It was also noted that simulation 
modeling can advance the holistic view and can support improvement work and learn-
ing. Finally, Study IV established that the focus group discussion was a useful method 
for learning about how the participants experienced the use of the simulation model.  
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7 DISCUSSION 
To better manage the challenges of chronic care, this thesis presents approaches for 
managing complexity, empowering patients and supporting learning for patients and 
providers. This thesis explores various challenges in providing care for patients suffer-
ing from chronic rheumatoid arthritis, specifically the challenges that arise in the inter-
action between the patients and their health care providers (patient level) and in pa-
tients’ access to care (clinical level).  
 
The two approaches – the Feed Forward System (FFS) and simulation modeling – to-
gether constitute a proposed upgrade that can support chronic care re-design. Both ap-
proaches are based on Information and Communication Technology (ICT) and facili-
tate gathering and managing data that can create an understanding and learning oppor-
tunity in the transformation of data and information into knowledge and action and fi-
nally to improvement.  
 
7.1 FEED FORWARD SYSTEMS  
The purpose of the FFS is to influence the outcome of a process before it has been initi-
ated. In the context of rheumatology it aims to capture data from patients to facilitate 
the patient–provider interaction. Patients can review their personal data which has been 
recently entered in the system and can compare these data to data from previous entries. 
In this way, patients can easily follow the progress of their disease and the results of 
their treatments over time (Study I).  
 
The subjective experience of pain and/or the inability to perform daily routines is 
turned into explicit, concrete, and measurable data points. This can enable the trans-
formation from tacit to explicit knowledge and may create learning opportunities for 
patients (Nonaka, 1994). When single data points are viewed in comparison, they can 
inform decisions about future actions to take (Study I). As Carina stated in The Patient 
Journey, she is an expert on her body and how her disease affects her body. With the 
use of the FFS she can translate that knowledge in a way that is accessible and assessa-
ble for her doctor.  
 
Study I shows that by using the FFS, patients are better prepared, informed, and in-
volved in their own care. FFS allows patients and providers to use the same data and 
language when making joint decisions on future treatment. In this way, patients and 
providers may become empowered as they meet in the shared decision making process. 
The interaction between patients and providers can be facilitated by the common lan-
guage of the FFS that helps patients and providers to focus on what is important during 
the visit (Study I). The common language has previously been described as a vital part 
of the patient–provider interaction in chronic care (McCorkle et al., 2011). 
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The overview can also support communication on sensitive topics such as mental 
illness. Moreover, Study I showed that the FFS can help make patients become 
more active during their clinical visits. Such activity has been identified as an im-
portant factor in the patient–provider interaction (Pilnick and Dingwall, 2011). 
When patients become more involved and active this can enable self-management 
later on. For Carina, the overview has become a guide for her actions between her 
interactions with healthcare. 
 
Monitoring the disease and regularly gathering data can help patients detect prob-
lems and act proactively (Bergman et al., 2011). By using the FFS from home, ICT 
can help patients communicate with healthcare by identifying when they are in need 
of care and eliminate unnecessary visits that could obstruct access for patients with 
a greater need of care.  
 
Caring for patients with chronic diseases is a multifaceted task due to the vast 
amount of EHR information, treatment opportunities and combinations and patient 
preferences. The patient overview, which is generated by the FFS, is a record of 
what has been jointly decided during the clinical visits. It is compiled in a way that 
is useful to providers in the decision making process (Study I). The data in the FFS 
can support benchmarking between patient groups and clinics in improving quality 
of care (Study I). In particular, the overview illustrates how data can be transformed 
into information on treatment effects and then into knowledge on how to proceed 
based on the feedback. 
 
Similar examples of the FFS and computerized questionnaires in the context of 
rheumatology have been reported elsewhere (Greenwood et al., 2006, Richter et al., 
2008). The instant provision of results was appreciated (Greenwood et al., 2006) al-
so valued in Study I. While some providers raised the concern that certain patient 
groups might find it difficult to use the FFS in Study I, findings from Greenwood et 
al. (2006) suggest that the use of the touch screen questionnaire can be acceptable 
regardless of the patients’ age and previous experience with computer use 
(Greenwood et al., 2006). Similar to the findings of Study I, the instantly available 
data offers support for clinical decision making that can improve health care quality 
and support patient empowerment (Richter et al., 2008). 
 
7.2 SIMULATION MODELING 
Study II suggests there are opportunities for simulation modeling to assist 
healthcare improvement in making informed decisions. This was reinforced in 
Study IV where focus group discussion participants saw the benefit of testing to see 
how changes can affect the whole. Also, Study III exemplifies how simulation 
modeling can support clinical process re-design when trying to improve access.   
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In a collaborative effort of mapping processes, gathering data, forming questions, mod-
eling and testing changes in a virtual reality (as in Study II, Study III and Study IV) 
implicit knowledge and assumptions are made explicit. The simulation of models helps 
in the visualizing of interactions of processes and in the testing of different scenarios 
which can support informed decision making (Study II). Without risking the conse-
quences of making changes and possible mistakes in real life, simulation modeling can 
support testing in a safe environment in order to explore different options before mak-
ing decisions about which changes to implement.  
 
Simulation modeling can be linked to healthcare improvement work when comple-
mented by the PDSA cycle (Study II). The difficulties in planning and sustaining im-
provement work using the PDSA cycle (Baxley et al., 2011) may be alleviated by the 
use of the PSDSA model (Study II) (see Figure 9). The timing and placement of simu-
lation modeling in the PDSA cycle was mentioned in Study IV, emphasizing the struc-
ture of the PSDSA model from Study II. Simulation modeling is suitable when initiat-
ing improvement work. It is in the start-up phase when planning different changes that 
simulation modeling can help refine the changes to actually be implemented. 
Healthcare improvement initiatives can be iteratively tested in silico instead of in reali-
ty, and launched when the model presents output that meets the desired goals and im-
provements (Study II). 
 
The ability to test in safe environments, defined as “micro worlds”, has been proposed 
as an essential element in organizational learning (Senge, 1994). A similar concept 
called virtual worlds allow decision-makers to use a safe and low cost laboratory for 
testing and rehearsing (Sterman, 2006). Effective learning depends on instant feedback 
without time delays, which in turn can support change in mental models (Sterman, 
2006). Learning opportunities and the generation of new insights from simulation mod-
eling has previously been acknowledged as intangible products (Pidd, 2004a).  
 
Simulation modeling is recognized as a way to capture complex relations within a sys-
tem (Slovensky and Morin, 1997) also shown in Study II. Simulation modeling can 
advance understanding by displaying the cause and effect of changes in the healthcare 
context where many processes, stakeholders, decisions and systems interact, adding to 
the complexity of healthcare (Sterman, 2006, Bar-Yam, 2005, Eldabi, 2009, Slovensky 
and Morin, 1997). The possibility to view how changes cause effects in a larger context 
and over a longer time span, illustrates how data put into a model can be transformed 
into actionable knowledge. This knowledge may assist providers and managers in im-
proving healthcare. 
 
Simulation studies performed in the context of chronic care most often involves the 
System Dynamics method (Homer et al., 2007). Simulation research in rheumatology is 
scarce, but outpatient departments have been studied using simulation modeling quite 
frequently (Elkhuizen et al., 2007, Rohleder et al., 2007, Huarng and Lee, 1996, Chand 
et al., 2009). Study III showed that simulation modeling suits the challenges of rheuma-
tology when trying to improve access to care. The use and capture of evidence from 
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clinical trials into the model to propose clinical re-design, demonstrates the power of 
simulation modeling in performing research. This is one of the factors contributing to 
the proposal of simulation modeling as the third branch of science after theory and ex-
perimentation (Pool, 1992). 
 
Despite the many reported simulation modeling projects, little has been written about 
their real life implementation or value in improving healthcare (Brailsford et al., 2011, 
Fone et al., 2003). This aspect was obvious in Study II, where only 24% of the retrieved 
articles mentioned implementation or decision support experiences. Instead, articles of 
simulation modeling projects tend to end when the simulation model is completed, 
without any real change being effected (Study II). Study IV was intended to illustrate 
the use and potential value of simulation modeling at the clinical level. 
 
This knowledge gap is acknowledged as one of the most important issues in the re-
search on Operations Research (OR) in healthcare services (Brailsford et al., 2011, 
Eldabi, 2009). To resolve this issue, research focus has often been on the barriers of 
implementation of simulation modeling which has revealed  these to include healthcare 
culture and incentives, costs of simulation software, and poor availability and quality of 
data (Brailsford, 2005, Eldabi, 2009).  
 
7.3 FROM DATA TO DECISION 
The two approaches described above, FFS and simulation modeling, represent two dif-
ferent ways of transforming data into knowledge that can inform decisions. This 
movement is explained by the Data Information Knowledge Wisdom (DIKW) model. 
The model originates from the 1930s and was further developed by the systems theorist 
Russell Ackoff in 1989 (Rowley, 2007). The model has previously been applied within 
the areas of knowledge management, information management, information systems 
(Rowley, 2007) and in nursing informatics (Matney et al., 2011).  
 
The components of the DIKW model starts with data that is the raw material and 
presentations of symbols (Fricke, 2009). Information represents processed, relevant or 
useful data (Fricke, 2009) and allows answers to questions of who, what, where and 
when (Rowley, 2007). The collection of information and understanding that allows 
instructions to be created represents knowledge (Fricke, 2009, Rowley, 2007). Wisdom 
is the least often defined or used part of the model (Fricke, 2009, Rowley, 2007). The 
meaning of wisdom varies and includes contextualizing information, knowing why, 
evaluating and understanding (Rowley 2007), applying know-how (Fricke, 2009), and 
experiences (Matney et al., 2011).  
 
The DIKW model, applied to this thesis can be used to illustrate how data in the patient 
overview is transformed into knowledge. It can also show the transformation of infor-
mation into knowledge when using simulation modeling. The combination of instant 
feedback, provided by the FFS and simulation modeling can contribute to informed 
decisions.  
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7.4 CHALLENGE MEETS UPGRADE 
The developments in rheumatology as described in the introduction have created organ-
izational challenges. With more treatment possibilities, more patients can be treated 
more effectively. Patients with a controlled disease activity still require surveillance of 
their heavy drug treatment. The volume and diversity of patients’ needs pose challenges 
to the healthcare delivery system and to patient access.  
 
Feed Forward Systems and simulation modeling represent an upgrade of how to man-
age the challenges inherent to rheumatology care. This is enabled through the shared 
features of FFS and simulation modeling. Both approaches share the ability to trans-
form data into information and knowledge through the use of instant feedback. From 
data, gathered systematically over time using the FFS, patterns can be identified that 
provide feedback in real time and that can be used to inform the next action step. In-
stant feedback and real time data can help render action into reality (Neuhauser et al., 
2011), which can be accomplished by the use of simulation modeling for providers and 
managers. 
 
Another similarity concerns the multiple stakeholders involved. FFS is best used by 
patient and provider jointly, as shown in Study I. Simulation modeling can be used by 
the provider, who suggests an improvement for testing, by the manager who can make 
the decision to implement it, or by the providers who will implement the improvement 
in practice. FFS and simulation modeling form a mutual communication platform that 
creates a space for joint sharing of views. Feedback from the FFS and from simulation 
modeling can create opportunities for self-correction at an early stage in the process of 
either deciding on the next treatment step or making improvements to launch into reali-
ty.  
 
7.5 METHODOLOGICAL CONSIDERATIONS  
Qualitative and quantitative research methods have been used to fulfill the aim of this 
thesis. Data were collected by means of interviews and a focus group (Study I and 
Study IV), questionnaires (Study I), and simulation modeling (Study III). In quantita-
tive research, the terms validity, reliability and generalizability are relevant. However, 
in qualitative research, these issues are addressed by the concept of trustworthiness, 
which includes credibility, transferability, dependability, and confirmability (Marshall 
and Rossman, 2006, Creswell and Creswell, 2007, Lincoln and Guba, 1985).  
 
When constructing questionnaires, important factors to be considered are sampling, 
question design, reliability, and validity (Fowler, 2009). The questionnaire and inter-
view guides in Study I were translated from Swedish to English, however without a 
back translation which is considered practice and important in maintaining reliability of 
the instrument. Reliability refers to the accuracy of the measuring instrument or proce-
dure whereas validity concerns the degree to which a study accurately reflects or as-
sesses what the researcher is attempting to measure (Robson, 2002). Instead of back 
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translation, the questionnaire in Study I was pilot tested to obtain useful information on 
wording, question design, question order, and scale, which potentially increased the 
reliability. 
 
Study IV is limited by the fact that only one focus group discussion and two interviews 
were conducted. The workshop focus group method used to introduce simulation mod-
eling to healthcare providers had certain limitations. Feedback from the focus group 
revealed, for example, that the lack of time resulted in inadequate understanding and 
application of the model. Also, the participants were new to simulation modeling as a 
method. The importance of developing and explaining the model’s logic step-by-step 
and to respond to questions and problems (Pidd, 2004, Aharonson-Daniel et al., 1996, 
Alkaabi et al., 2006, Cochran and Bharti, 2006) is recognized. Study IV was a pilot 
study in the sense of exploring how focus group discussions could be used in studying 
the experience of using simulation models at the clinical level.  
 
In performing a meta-analysis, there are many possible limitations to manage, for ex-
ample, in the selection of databases, search terms, and selection criteria as well as in the 
interpretation of findings. Perspectives on the research context and culture where the 
researchers are situated can influence the terms and databases used in the literature 
search (Anagnostou et al., 2011). To deal with these matters the research team aimed 
for transparency of the entire research process. In addition, tasks that might be subject 
to interpretation were checked. 
 
Dependability refers to consistency in the research process in terms of data collection 
and data analysis (Graneheim and Lundman, 2004). In Study I and Study IV, data were 
collected in similar ways for all participants. Since data collection periods were quite 
short in both studies, time or seasonal biases cannot be excluded. Confirmability refers 
to the corroboration of the findings. The research team performed data analysis jointly 
highlighting the topic of objectivity of the research process. The research team’s efforts 
permitted a review of each other’s work that confirmed evidence of similarities, identi-
fied differences, and led to new interpretations (Sandelowski, 1993, Graneheim and 
Lundman, 2004).  
 
7.5.1 The simulation modeling journey 
 
All models are wrong but some are useful 
  George E P Box (Box and Draper, 1987)
4
 
 
 
Study III provided challenges that are described further here. Of the several important 
steps in the simulation modeling project, I focus here on the steps for the validation, 
verification and testing of the model.  
 
                                                 
4
 Page 74. 
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The intent of simulation modeling is not to reflect all aspects of reality since such a 
portrayal is neither possible nor desired (Pidd, 2004a, Gilbert and Troitzsch, 2005). 
Nevertheless, the verification, validation, and testing of models is of great importance 
(Gilbert and Troitzsch, 2005, Banks, 1998). Banks (1998) names this process VV&T 
(Verification, Validation, and Testing). Verification refers to the construction of the 
model in a reliable manner; validation refers to the construction of the model so that it 
reflects a real life system; and testing refers to the process of checking for errors and 
inconsistencies (Banks, 1998, Robinson, 2004, Gilbert and Troitzsch, 2005). To in-
crease the chances of successful model implementation, model credibility is important. 
Such credibility includes model validity, stakeholder participation and the use of re-
spectable methods and analysts (Steins et al., 2010).  
 
Study III, which involved access to data from multiple sources, required close coopera-
tion with healthcare providers, researchers, and modelers on the project team. This co-
operative strategy aimed to verify and validate the simulation model created. The strat-
egy also permitted constant checking of the model output against model input for vari-
ous scenarios. The research team was thus able to test model data against real life data 
in an iterative testing sequence.  
 
Despite the strong emphasis on the validation and verification process, this is the step 
most often lacking in the research articles of the meta-analysis (Study II). The conse-
quences of the failure to verify and validate model data can, of course, lead to mislead-
ing model output. Hence, it is essential to eliminate errors early in the process (Banks, 
1998). The built-in compiler in the simulation software detects coding errors whereas 
logical errors are detected when running the model and when presenting model output 
to researchers. Logical errors can be difficult to spot in complex models. The designed 
user interface helped us visualize and detect some errors in our model.   
 
Study III revealed the difficulties in simulation modeling, with its VV&T processes. 
Further testing after the completion of Study III resulted in the development of a new 
version of the simulation model. The second version of the simulation model was de-
veloped as part of new clinic assessments aided by the availability of new data about 
the use of DAS28 over time (SRQ, 2011). The same staffing arrangement as in the first 
version was used and modifications of the second version of the model (see parameter 
table in Appendix) included four changes.  
 
First, the clinic’s open hours from those in the first model were changed. This change 
meant that the providers at the clinic would no longer initiate new visits in the 35 
minutes before the clinic’s closing time. The second change related to the intervals be-
tween nurse visits in the Open clinic that previously were set using a triangular distribu-
tion (2, 8, and 14 months). The new and constant value, which rheumatologists thought 
was more accurate, was set to 12 months. The third change involved the criterion for 
the Open-Tight clinic that is based on DAS28 and was changed from 3.2 to 3.4. The 
fourth change dealt with the fact that patients remain at the same time intervals, irre-
spective of the DAS28 progression in the Standard system. Thus, patients whose condi-
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tion deteriorates, in reality begin at step one in the time interval series that controls the 
time between visits.  
 
The second version of the model simulated twelve years, with a warm-up time of seven 
years that was excluded from the analysis. The warm-up time was chosen based on 
when resource utilization in the Standard system reached a steady state. In the output 
analysis, the steady state of the model was defined as the point when the average re-
source utilization in the Standard setting does not change more than 1% per year. The 
new results are presented in Table 5.  
 
Results from the developed model show that resource utilization is lower in both sys-
tems (Standard and Open-Tight). Waiting times for the initial visit are similar to the 
first model. However, for follow up visits, the waiting time is longer in the Standard 
system and lower in the Open-Tight system. Costs are lower in the Open-Tight system 
(as revealed in Study III) because, as expected, the resource utilization is lower and the 
doctors and nurses share the work load. 
 
Second version of model Standard Open-Tight 
Resource utilization (mean) 94.1% 88.3% (MD) 
74.6 % (RN) 
Waiting time in days (mean) 
 
IV=0.1 
FV=44 
IV=1.0 
FV MD=11.6 
FV RN=0.8 
Costs in 1000 SEK (total) 11 188 7 467 
 
Table 5. Summarized results from the revised version of the model in Study III. The simulation 
includes holiday schedules. IV = Initial Visit, FV = Follow-up visit, MD = Medical Doctor, RN = 
Registered Nurse. 
 
The experience of working with the simulation model used in Study III has resulted in 
the development of a business model useful for future simulation projects. The business 
model is based on the experience of the research team and the literature, mainly the 
Soft Systems Methodology (SSM), which Peter Checkland originally developed 
(Checkland, 1981). The core features of this business model are joint workshops and 
meetings with organization representatives that develop an understanding of challenges, 
questions, expectations, data, processes, and delivery formats. These features will be 
used in the planning, execution, implementation, and evaluation of the simulation mod-
el in future projects.  
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8 CONCLUSIONS 
Feed Forward Systems and simulation modeling represent an upgrade of how to man-
age the challenges inherent to rheumatology care. The FFS encourages patient empow-
erment, self-management, shared decision making and support learning for patients and 
providers alike. Simulation modeling is an approach to managing complex problems 
and facilitating learning for providers and managers. 
 
This is enabled through the shared features of FFS and simulation modeling: (1) trans-
formation of data into knowledge, (2) a mutual communication platform for multiple 
stakeholder involvement, (3) provision of real time feedback that enables action in clin-
ical practice, and (4) self-correction that generates learning opportunities. 
 
8.1 IMPLICATIONS FOR PATIENTS AND CLINICS 
Beginning at the patient level, patients and providers can use a common language of-
fered by the FFS. This allows patients to be more involved in and informed about their 
care. The patient overview supports the providers in making informed decisions on 
future treatment. 
 
At the clinical level, simulation modeling can be used as a tool for improvement when 
testing the effects of rheumatology care process re-designs. Simulation modeling can 
also support improvement by visualizing the effects of planned changes, communi-
cating these changes to management, and engaging healthcare staff to explore and test 
innovative solutions. In other words, the introduction of the FFS and simulation model-
ing has the potential to help providers and patients to change the healthcare system 
from within. 
 
8.2 FUTURE RESEARCH 
Several ideas and questions have emerged during this journey of exploration and some 
areas where research opportunities have been identified are the following:   
- The effect of simulation modeling in a setting where simulation modeling has 
been used for learning 
- The effects of using FFS and simulation modeling in other chronic care settings 
- The impact of FFS on patients’ health outcomes 
- The implementation aspects of FFS and of simulation modeling 
- Developing coaching and simulation as a part of healthcare improvement 
 
In summary, the upgrade proposed in this thesis need to be continually developed 
through practice and research if we are to manage the challenges of chronic care to 
match the needs of patients like Carina.  
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11 APPENDIX 
 
11.1 STUDY I 
 
11.1.1 Patient questionnaire Swedish settings 
Denna enkät är framtagen för att fånga upp patienters åsikter om RA-registret för att på så sätt 
kunna förbättra registret för användarna. Med termen system avses RA-registret. 
 
1. Hur är ditt helhetsintryck av systemet (RA-registret)? (Ringa in det alternativ som 
passar bäst) 
 
          Mycket bra       Bra       Medel       Dåligt       Mycket dåligt 
 
          Kommentar:____________________________________________________ 
 
    
2. Var systemet lätt eller svårt att förstå? (Ringa in det alternativ som passar bäst) 
 
          Mycket lätt        Lätt        Medel        Svårt       Mycket svårt 
            
         Kommentar:_____________________________________________________ 
 
    
3. Var det lätt eller svårt att förstå hur du skulle gå vidare i systemets olika delar? 
(Ringa in det alternativ som passar bäst) 
 
           Mycket lätt        Lätt        Medel        Svårt       Mycket svårt 
 
         Kommentar:_____________________________________________________ 
 
    
4. Skulle du uppskatta möjligheten att kunna registrera dina data hemifrån alt från 
jobbet?  (Ringa in det alternativ som passar bäst) 
 
 Ja                              Nej                     Har ej tillgång till dator 
 
    Kommentar:_____________________________________________________ 
 
    
 
5. Upplevde du något/några problem vid användandet av systemet?  
              (Ringa in det alternativ som passar bäst) 
 
  Ja                                                     Nej 
 
        Om du upplevde några problem, vilket/vilka var det?_____________________ 
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6. Vill du registrera något annat än det som systemet erbjuder?  
     (Ringa in det alternativ som passar bäst) 
 
           Ja                                                      Nej 
          
         Om ja, vad vill du i så fall registrera?_________________________________ 
 
    
 
7. Vill du registrera på något annat sätt än det som systemet erbjuder? 
             (Ringa in det alternativ som passar bäst) 
 
                       Ja                                                      Nej          
 
         Om ja, hur vill du i så fall registrera?_________________________________ 
 
    
 
8. Är diagrammen lätta eller svåra att tolka? 
             (Ringa in det alternativ som passar bäst) 
 
          Mycket lätt        Lätt        Medel        Svårt       Mycket svårt 
 
         Kommentar:_____________________________________________________ 
 
    
 
9. Vilka fördelar har systemet? 
» ____________________________________ 
» ____________________________________ 
» ____________________________________ 
 
10.  Vilka nackdelar har systemet? 
» ____________________________________ 
» ____________________________________ 
» ____________________________________ 
 
 
11.  Är du van vid att använda datorer?  
               (Ringa in det alternativ som passar bäst) 
 
               Mycket         Medel       Lite        Inte alls 
 
 
12. Vilket år är du född?_______ 
 
Tack för din medverkan! 
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11.1.2 Patient questionnaire for U.S. setting 
 
Questionnaire (Please mark the choice that corresponds with your opinion.) 
 
1. What was your overall impression of the computer based Health Survey? 
 
 Excellent Very Good            Good      Fair             Poor 
 
2.  Was the Health Survey easy or difficult to understand? 
 
 Very Easy Easy Ok   Difficult Very Difficult 
 
3.  Was it easy or difficult to understand how to move forward in the Health Survey? 
 
 Very Easy Easy Ok   Difficult Very Difficult 
 
4.  Would you like the chance to complete the Health Survey prior to your  
     appointment using your home or work computer? 
 
 Yes No  Do not have access to a computer 
 
5.  Did you experience any problems completing the Health Survey process? 
 
 Yes No 
If yes, please define the problem:   ___________ 
       
 
6.  Is there other information that you think the Health Survey should ask about? 
 
 Yes No 
If yes, please describe the information:     
       
 
7.  Would you like to be able to complete the Health Survey in any other way (than  
     by computer?) 
 
 Yes No 
If yes, please list options:      
       
 
8.  Would you like to complete the Health Survey before your appointment using the  
     internet? 
 
 Yes No 
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9.  How familiar are you with using computers? 
 
 Very Familiar      Familiar Not Familiar 
 
10.  Please list advantages and disadvantages of the system 
     Advantages 
 *      
 *       
 *      
 *      
     Disadvantages 
 *      
 *      
 *      
 *      
 
Comments: 
       
       
       
 
Demographic Information: 
 
Age   
 
Gender: Female Male  
(Please circle one) 
 
Occupation       
 
Thank you for your participation! 
 
 
11.1.3 Patient Interview guide, Swedish settings  
 
1. Hur uppfattar du läkarens åsikt om systemet? 
 
2. Hur påverkar systemet läkarbesöken? Underlättar de eller ej? 
 
3. Tror du systemet kan påverka kontakten mellan dig och läkaren? 
 
11.1.4 Provider Interview guide, Swedish settings  
 
1. Hur länge har du arbetat med RA-registret? 
 
2. Har systemet påverkat dina arbetsrutiner? Om ja i så fall hur? 
 
3. Är arbetet med systemet värt besväret? 
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4. Hur påverkar systemet besöksrutinen?  
 
5. Vad tror du det finns för långsiktiga effekter av systemet? 
 
6. Vad tror du skulle ske om alla patienter använde sig av systemet? 
 
7. Kan du tänka dig någon situation där RA-registret inte ska användas? 
 
8. Vad gör du om RA-registret inte fungerar? Hur påverkar detta ditt arbete? 
 
9. Finns det något i RA-registret som du skulle vilja ändra på? 
 
10. Känns systemet säkert? 
 
11. Hur uppfattar du patienternas åsikt om systemet? 
 
12. Tror du registreringen kan påverkas om patienten registrerar hemifrån? 
 
13. Vilka fördelar har systemet? 
 
14. Vilka nackdelar har systemet? 
 
 
11.1.5 Patient Interview guide, U.S. setting 
 
1. What do you think was the provider’s opinion of the computer-based Health Survey? 
 
2. How did the computer-based Health Survey affect your visit?  Is it different from other 
visits you have experienced? 
 
3. What influence or impact do you think that the computer-based Health Survey had on 
the interaction between you and your provider? 
 
4. Did your provider show you the answers to your Health Survey?  If yes, was it helpful? 
 
5. Did you find the diagrams and results easy or difficult to interpret? 
 
 
11.1.6 Provider Interview guide, U.S. setting 
 
1. What is your occupation? 
 
2. Do you use the system in your daily work? 
 
3. For how long have you worked with the system? 
 
4. Is the work with the system “worth the effort?” 
 
5. In your opinion, what are the long term effects of the system? 
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6. Is there any situation where the system cannot be used? 
 
7. Is there anything in the system that you would like to change? 
 
8. What is your impression of the patient’s opinion of the system? 
 
9. What advantages does the system possess? 
 
10. What disadvantages does the system possess? 
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11.2 STUDY III 
Parameter table used in Study III with updated simulation setting for the second version 
of the simulation model. Parameters in italics represent change made from the initial 
settings. 
 
 
Category Parameter Parameter 
description 
Default set value(s) 
Differences in italic 
   Initial setting Second version 
setting 
P
a
ti
e
n
ts
 a
n
d
 r
e
s
o
u
rc
e
s
 
Patient referral 
inflow  
Average patient 
referral inflow per 
day 
4 4 
Number of 
available 
examination 
rooms 
Available 
examination rooms 
in the outpatient 
department 
10 10 
Number of 
nurses in 
service 
During regular 
working weeks, 
summer and winter 
holiday period 
0 in Standard, 3 in 
OT. During holidays, 
1 in OT. 
0 in Standard, 3 in OT. 
During holidays, 1 in 
OT. 
Number of 
doctors in 
service  
During regular 
working weeks, 
summer and winter 
holiday period 
 
 
8 in Standard, 5 in 
OT. During holidays, 
2 in Standard and 1 
in OT. 
8 in Standard, 5 in OT. 
During holidays, 2 in 
Standard and 1 in OT. 
Working hours 
for the clinic, 
summer and 
Christmas 
schedule 
Open hours for the 
clinic.  
8:30-12:00 pm  
1:00- 4:00 am  
(Mon-Fri). Summer 
(July 1st to August 
15th) and Christmas 
(December 24th to 
January 7th) 
8:30-12:00 pm  
1:00- 4:00 am  
(Mon-Fri). Summer 
(July 1st to August 
15th) and Christmas 
(December 24th to 
January 7th) 
Resource cost Given in units per 
hour 
Doctor 300 SEK/h 
Nurse 150 SEK/h 
Room 50 SEK/h 
Doctor 300 SEK/h 
Nurse 150 SEK/h 
Room 50 SEK/h 
D
o
c
to
r 
ti
m
e
 a
n
d
 p
ri
o
ri
ty
 
Doctor 
appointment 
duration 
Defined as (min, 
avg, max), gives 
samples from 
uniform or triangular 
distribution 
(30, -, 45) min (30, -, 45) min 
Doctor 
appointment 
priority 
Possible to prioritize 
for example Initial 
visits higher than 
Follow-up visits 
No priority distinction 
between Initial visits 
and Follow-up visits 
No priority distinction 
between Initial visits 
and Follow-up visits 
Time between 
doctor visits in 
Tight clinic 
Defined as (min, 
avg, max), gives 
samples from 
uniform or triangular 
distribution 
(1, 2.5, 4) months (1, 2.5, 4) months 
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O
p
e
n
 a
n
d
 T
ig
h
t 
s
y
s
te
m
 s
e
tt
in
g
s
 
Time between 
doctor visits in 
Open Tight 
Special Clinic 
(OTC) 
Defined as (min, 
avg, max), gives 
samples from 
uniform or triangular 
distribution 
(3, 6, 12) months (3, 6, 12) months 
Time between 
nurse visits in 
Open Clinic 
Defined as (min, 
avg, max), gives 
samples from 
uniform or triangular 
distribution 
(2, 8, 14) months (12, 12, 12) months 
Health 
improvement 
between visits  
Measured by 
DAS28, defined as 
(min, avg, max), 
gives samples from 
uniform or triangular 
distribution 
(-4, 0, 4) (-4, 0, 4) 
Criterion for 
discharge, CD 
Related to DAS28 2.6 2.6 
Criterion for 
Open or Tight, 
COT 
Related to DAS28 3.2 3.4 
Exception to 
COT  
Percentage of Open 
clinic patients sent 
to Tight and vice 
versa  
5% / 15% 5% / 15% 
Probability to 
initial visit 
Percentage of 
patients from 
referral to initial visit 
82% 82% 
Probability to 
follow-up visit 
Percentage of 
patients from initial 
visit called to follow-
up visit 
65% 65% 
S
im
u
la
ti
o
n
 s
e
tt
in
g
s
 
Simulation time Years to simulate, 
default setting, 
(range) 
10 yrs (1-20) 8 yrs (1-20) 
Warm-up time Years before the 
system is 
considered to be 
“warm” and results 
are analyzed, 
default setting 
(range) 
2 yrs (0-5) 2 yrs (0-5) 
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11.3 STUDY IV 
 
11.3.1 Focus group questions 
 Introduktion 
o Berätta kort om er upplevelse av att arbeta med en simuleringsmodell 
o Berätta kort om hur det gick att arbeta med era frågor och arbete två och två 
o Var resultaten som ni fick fram förväntade eller såg ni något oväntat? 
o Till vilka frågor passar inte simulering? 
o Vad ser ni för fördelar med att arbete med en simuleringsmodell jämfört med att 
testa i praktiken? 
o Vad ser ni för nackdelar med att arbete med en simuleringsmodell jämfört med att 
testa i praktiken? 
o Upplevde ni några insikter eller aha-upplevelser under simuleringens gång? 
 
 Var och när 
o Vilka frågor och områden tycker ni simulering kan passa bäst till? 
o Kan förbättringsarbete vara ett område och i så fall hur? 
o Vilka kan vara potentiella användare till simulering I hälso- och sjukvården? 
 
 Simulering och förbättringsarbete 
o Hur skulle simulering kunna hjälpa er i ert förbättringsarbete? 
o Har denna workshop hjälpt er framåt på något sätt? 
o Kan simulering hjälpa er i ert framtida förbättringsarbete? 
 
 Värde och trovärdighet 
o Kände ni att ni kunde lita på simuleringsmodellen? 
o Kände ni att simuleringsmodellen återspeglade er klinik och dess processer? 
o Beskriv/fundera öppet kring det potentiella värdet med simulering 
 
 
11.3.2 Interview questions 
1. Hur är läget generellt sett på kliniken, hur ser er arbetsbelastning ut nu och vid till-
fället för workshoppen  
2. Beskriv dina tankar efter workshoppen. 
3. Har du och dina kollegor diskuterat workshoppen och simulering något efteråt?  
a. Om ja/nej, vad eller varför inte tror du? 
4. Har workshoppen lett till nya idéer, diskussioner på kliniken eller insik-
ter/reflektioner? 
a. Om ja/nej, vad eller varför inte tror du? 
5. Har ni valt att göra något annorlunda efter workshopen?  
6. Om du får tänka dig en optimal simuleringsmodell, vad skulle den innehålla? 
7. Hur skulle den kunna hjälpa dig i ditt arbete? 
8. Vilka kopplingar ser du mellan simulering och förbättringsarbete? 
9. Hur tror du att simulering kan bidra till lärande (individ och organisation)? 
10. Hur skulle du berätta om simulering för någon som inte vet något om ämnet och som 
inte var med på workshoppen?  
 
